What if Teva submitted an Amicus saying that a settlement for the Marine indication was a better business decision than pursuing an ANDA for a product that would be priced similarly to the name brand?
Mrmain, i believe if there are amicus briefs they will highlight different angles from the Singer brief. I posted a link to an article mentioning that judges pay less attention to amicus briefs if they just rehash the appellant’s brief.
Don't forget there will probably be Amicus briefs on behalf of the generics, I presume from consumer advocate groups. We're on the wrong end of the stick if this becomes a public relations battle, consumers care about cheaper prices and are not going to care about our portfolio or how unfair this is to Amarin.
The appellate court is supposed to determine if the lower court correctly invalidated the obviousness patent. Outside of that is activism/political on both sides of the spectrum although most on this board are blind to the other side.
Don't get me wrong I'll take it if the court favors Amarin.
News 
Market Data 
Discover 
